<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00317668</url>
  </required_header>
  <id_info>
    <org_study_id>autoimmunepi-HMO-CTIL</org_study_id>
    <nct_id>NCT00317668</nct_id>
  </id_info>
  <brief_title>Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      The investigators will check the serum of epilepsy patients for antibodies against glutamate&#xD;
      receptors and double stranded DNA. They will characterise the patients (by the kind of&#xD;
      epilepsy, autoimmune disease comorbidity, and cognitive profile).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2006</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Epilepsy</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  120 epilepsy patients from the epilepsy clinic and Emergency Room (ER)&#xD;
&#xD;
          -  Controls: 100 patients with other neurological diseases and no epilepsy; and 30&#xD;
             healthy volunteers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Ekstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dana Ekstein, MD</last_name>
    <email>dekstein@md.huji.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Ein-Kerem Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dana Ekstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2006</verification_date>
  <study_first_submitted>April 23, 2006</study_first_submitted>
  <study_first_submitted_qc>April 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2006</study_first_posted>
  <last_update_submitted>April 29, 2007</last_update_submitted>
  <last_update_submitted_qc>April 29, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

